Cargando…
Molecular targeted therapy for anticancer treatment
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for certain types of cancer, molecular targeted therapy utilizing small molecule agents or therapeutic monoclonal antibodies acting as signal transduction inhibitors has served as a fundamental backbone in precis...
Autores principales: | Min, Hye-Young, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636149/ https://www.ncbi.nlm.nih.gov/pubmed/36224343 http://dx.doi.org/10.1038/s12276-022-00864-3 |
Ejemplares similares
-
Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016) -
Molecular Targets of Genistein and Its Related Flavonoids to Exert Anticancer Effects
por: Chae, Hee-Sung, et al.
Publicado: (2019) -
Targeting senescence as an anticancer therapy
por: Bousset, Laura, et al.
Publicado: (2022) -
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
por: Han, Jang Mi, et al.
Publicado: (2022)